John Leonard - Quintiles Transnational Independent Director

Director

Dr. John M. Leonard, M.D. is Independent Director of Company. Since July 2014, Dr. Leonard serves as Executive Vice President, RD, at Intellia Therapeutics, Inc., a biotechnology company involved in genebased therapy. Dr. Leonard previously served as the Chief Scientific Officer and Senior Vice President of Research and Development at AbbVie Inc., a global pharmaceutical company, from its spinout from Abbott Laboratories in January 2013 until retiring from those positions at the end of 2013. Prior to the formation of AbbVie, Dr. Leonard served as Senior Vice President of Global Pharmaceutical Research and Development at Abbott from 2008 to 2012. He has over 30 years of combined experience in medicine, research and management, including serving in various roles at Abbott beginning in 1992. Dr. Leonard also serves as a director of Chimerix, Inc. and Intellia Therapeutics, Inc. Dr. Leonard earned a Bachelors Degree in Biochemistry from the University of Wisconsin at Madison and a Doctorate in Medicine from Johns Hopkins University in Baltimore, MD. Dr. Leonard completed an Internship and Residency in Internal Medicine at Stanford University Hospital followed by a Postdoctoral Fellowship in Molecular Virology at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. Dr. Leonard serves as a member of the Audit Committee and as a member of the Nominating and Governance Committee. since 2015.
Age 58
Tenure 9 years
Professional MarksPh.D
Phone919-998-2000
Webwww.quintiles.com
Leonard earned a Bachelor’s Degree in Biochemistry from the University of Wisconsin at Madison and a Doctorate in Medicine from Johns Hopkins University in Baltimore, MD.

Quintiles Transnational Management Efficiency

The company has return on total asset of 4.03 % which means that for every 100 dollars spent on assets, it generated a profit of $4.03. This is acceptable considering the industry classification. Similarly, it shows a return on equity (ROE) of 1.89 %, implying that it made 1.89 on every $100 invested by shareholders. Quintiles Transnational's management efficiency ratios could be used to measure how well Quintiles Transnational manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 9.77 B in total debt with debt to equity ratio (D/E) of 130.0, indicating that it may be unable to produce cash to meet its debt commitments. Quintiles Transnational has a current ratio of 1.2, implying that it may have difficulties to pay its interest payments when they become due. Debt can assist Quintiles Transnational until it has trouble settling it off, either with new capital or with free cash flow. So, Quintiles Transnational's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Quintiles Transnational sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Quintiles to invest in growth at high rates of return. When we think about Quintiles Transnational's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Robert JenkinsAcco Brands
72
Kathryn McCarthySEI Investments
69
Pradeep JotwaniAcco Brands
66
Ben VeerRelx PLC ADR
67
James BuzzardAcco Brands
65
Kathleen MazzarellaWaste Management
61
Wilmot KiddSilvercrest Asset Management
76
Andres GluskiWaste Management
63
Alexander WhitelamSEI Investments
N/A
Nick LuffRelx PLC ADR
49
Michael NorkusAcco Brands
67
George BaylyAcco Brands
73
William PlummerWaste Management
62
Graciela MonteagudoAcco Brands
54
Kathleen DvorakAcco Brands
64
Frank ClarkWaste Management
73
Carol MillsRelx PLC ADR
63
Hans NorkusAcco Brands
73
Marike LelsRelx PLC ADR
61
Adrian HennahRelx PLC ADR
60
Thomas KroegerAcco Brands
72
Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. Quintiles Transnational (Q) is traded on New York Stock Exchange in USA and employs 36,100 people.

Management Performance

Quintiles Transnational Leadership Team

Elected by the shareholders, the Quintiles Transnational's board of directors comprises two types of representatives: Quintiles Transnational inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Quintiles. The board's role is to monitor Quintiles Transnational's management team and ensure that shareholders' interests are well served. Quintiles Transnational's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Quintiles Transnational's outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Pike, CEO and Director
Ari Bousbib, Director
Michael Evanisko, Independent Director
Leonard Schaeffer, Independent Director
James Erlinger, Executive Vice President General Counsel, Secretary
John Danhakl, Director
Richard Staub, President - Research and Development Solutions
Michael McDonnell, CFO, Executive Vice President
Kevin Gordon, COO
John Leonard, Independent Director
James Fasano, Director
Jonathan Coslet, Director
John Connaughton, Director
Haiyuan Lo, Director
Ronald Rittenmeyer, Director
Dennis Gillings, Executive Chairman of the Board
Todd Sisitsky, Director
Jack Greenberg, Independent Director
Kevin Knightly, President - Information and Technology Solutions

Quintiles Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Quintiles Transnational a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Quintiles Transnational in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Quintiles Transnational's short interest history, or implied volatility extrapolated from Quintiles Transnational options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Quintiles Transnational using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Consideration for investing in Quintiles Stock

If you are still planning to invest in Quintiles Transnational check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Quintiles Transnational's history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stocks Directory
Find actively traded stocks across global markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.